Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALC · against 76 other Healthcare companies of similar size
Ranked #35 of 77 · scores higher than 54% of peers
Bars: peers in each 10-point band of the valuation score20 peers with a valuation score of 50–59, including ALC · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ALC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 73 reported | 1.8% | 2.9% | 24% | 30% | |
| EBITDA yieldHigher is better · 78 reported | 6.2% | 5.3% | 57% | 50% | |
| Free cash flow yieldHigher is better · 53 reported | 4.5% | 3.9% | 63% | 20% | |
| Book yieldHigher is better · 72 reported | 61.7% | 20.1% | 90% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 31 | 28.7B USD | 63 | 52 | |
| 32 | 36.8B USD | 61 | 46 | |
| 33 | 21.4B USD | 60 | 67 | |
| 33 | 43.2B USD | 60 | 45 | |
| 35 | 35.0B USD | 59 | 52 | |
| 35 | 16.7B CHF (≈$19.2B) | 59 | 47 | |
| 37 | 73.2B SAR (≈$19.8B) | 58 | 56 | |
| 37 | 58.6B USD | 58 | 52 | |
| 39 | 8.24T JPY (≈$56.0B) | 57 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score